Staehler G, Drehmer I, Pomer S
Abteilung Urologie, Universität Heidelberg.
Urologe A. 1994 Mar;33(2):116-21.
In 45 patients with a vena cava tumor thrombus secondary to renal cell carcinoma we present the diagnostic and operative management and relevant data on the extent of the thrombus (classified into 4 stages), postoperative complications and patient survival. Extensive thrombi of the vena cava were removed surgically in hypothermia and with extracorporeal circulation. The importance of an interdisciplinary approach involving cardiac and urologic surgeons is therefore emphasized. With due consideration for relevant prognostic parameters such as tumor differentiation or spread, we estimated a 5-year survival of 29% for our Heidelberg patients. Neither the extent of the tumor thrombus nor tumor infiltration of the perirenal adipose tissue had any influence on patient survival.
我们报告了45例继发于肾细胞癌的腔静脉肿瘤血栓患者的诊断、手术治疗及相关数据，包括血栓范围（分为4期）、术后并发症和患者生存率。在低温及体外循环下，通过手术切除广泛的腔静脉血栓。因此强调了心脏外科医生和泌尿外科医生参与的多学科治疗方法的重要性。在充分考虑肿瘤分化或扩散等相关预后参数的情况下，我们估计海德堡患者的5年生存率为29%。肿瘤血栓范围和肾周脂肪组织的肿瘤浸润均对患者生存率无影响。
